{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:48:05Z","timestamp":1767134885321,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd005184","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2011,11,9]],"date-time":"2011-11-09T00:00:00Z","timestamp":1320796800000}}],"reference-count":34,"publisher":"Wiley","issue":"11","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd005184.pub2","type":"journal-article","created":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T14:13:36Z","timestamp":1320156816000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Creatine and creatine analogues in hypertension and cardiovascular disease"],"prefix":"10.1002","volume":"2011","author":[{"given":"Deborah L","family":"Horjus","sequence":"first","affiliation":[{"name":"Academic Medical Centre, University of Amsterdam; Department of Internal Medicine, Division of Vascular Medicine; Meibergdreef 9 Amsterdam Netherlands 1105 AZ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inge","family":"Oudman","sequence":"additional","affiliation":[{"name":"Academic Medical Centre, University of Amsterdam; Department of Internal Medicine, Division of Vascular Medicine; Meibergdreef 9 Amsterdam Netherlands 1105 AZ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gert A","family":"van Montfrans","sequence":"additional","affiliation":[{"name":"Academic Medical Centre, University of Amsterdam; Department of Internal Medicine, Division of Vascular Medicine; Meibergdreef 9 Amsterdam Netherlands 1105 AZ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lizzy M","family":"Brewster","sequence":"additional","affiliation":[{"name":"Academic Medical Centre, University of Amsterdam; Department of Internal Medicine, Division of Vascular Medicine; Meibergdreef 9 Amsterdam Netherlands 1105 AZ"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,11,9]]},"reference":[{"issue":"2","key":"10.1002\/14651858.CD005184.pub2-BIB0001|cit1","first-page":"187","article-title":"Controlled multicentric clinical study with placebo in patients with dilatative myocardiopathy functional class II-III N.Y.H.A. treated with oral phosphocreatinine","volume":"11","author":"Carmenini","year":"1994","journal-title":"CUORE RIVISTA DI CARDIOCHIRURGIA E CARDIOLOGIA"},{"issue":"9","key":"10.1002\/14651858.CD005184.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/clc.4960190905","article-title":"Hemodynamic effects of creatine phosphate in patients with congestive heart failure: a double-blind comparison trial versus placebo","volume":"19","author":"Ferraro","year":"1996 Sep","journal-title":"Clin Cardiol"},{"issue":"3","key":"10.1002\/14651858.CD005184.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0008-6363(95)00062-3","article-title":"Creatine supplementation in chronic heart failure increases skeletal muscle creatine phosphate and muscle performance","volume":"30","author":"Gordon","year":"1995 Sep","journal-title":"Cardiovasc Res"},{"key":"10.1002\/14651858.CD005184.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0011-393X(05)80478-3","article-title":"Multicenter controlled study of creatine phosphate in the treatment of heart failure","volume":"52","author":"Grazioli","year":"1992","journal-title":"Current Therapeutic Research"},{"issue":"3","key":"10.1002\/14651858.CD005184.pub2-BIB0005|cit5","first-page":"218","article-title":"Creatine supplementation improves muscle strength in patients with congestive heart failure","volume":"61","author":"Kuethe","year":"2006","journal-title":"Die Pharmazie"},{"issue":"2","key":"10.1002\/14651858.CD005184.pub2-BIB0006|cit6","first-page":"173","article-title":"Double-blind multicenter clinical trial on the efficacy of phosphocreatinine vs L-carnitine and placebo in a group of patients affected by heart disease","volume":"11","author":"Maggi","year":"1990","journal-title":"Acta Toxicol Ther"},{"issue":"2","key":"10.1002\/14651858.CD005184.pub2-BIB0007|cit7","first-page":"91","article-title":"An assessment of the activity of creatine phosphate (Neoton) on premature ventricular beats by continuous ECG monitoring in patients with coronary cardiac disease","volume":"21","author":"Pedone","year":"1984","journal-title":"Clinical trials journal"},{"issue":"6","key":"10.1002\/14651858.CD005184.pub2-BIB0008|cit8","first-page":"531","article-title":"Myocardial T1-201 scintigraphy in the study of the development of acute myocardial infarction. Evaluation of the effects of a drug with metabolic action: creatine phosphate","volume":"111","author":"Pedone","year":"1984","journal-title":"La Clinica Terapeutica"},{"issue":"2 Pt 1","key":"10.1002\/14651858.CD005184.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0002-8703(88)90611-4","article-title":"Reduction of ventricular arrhythmias by phosphocreatine (Neoton) in patients with acute myocardial infarction","volume":"116","author":"Ruda","year":"1988 Aug","journal-title":"Am Heart J"},{"issue":"2","key":"10.1002\/14651858.CD005184.pub2-BIB0010|cit10","first-page":"75","article-title":"[Initial experience with using phosphocreatine in patients in the early (up to 6 hours) period of myocardial infarction]","volume":"10","author":"Samarenko","year":"1987","journal-title":"Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR"},{"issue":"25-26","key":"10.1002\/14651858.CD005184.pub2-BIB0011|cit11","first-page":"576","article-title":"Use of phosphocreatinine in treatment of acute heart failure","volume":"49","author":"Zochowski","journal-title":"Pol Tyg Lek"},{"issue":"5","key":"10.1002\/14651858.CD005184.pub2-BIB0012|cit12","first-page":"649","article-title":"Effect of phosphocreatine in congestive heart failure","volume":"51","author":"Andreev","year":"1992","journal-title":"Current Therapeutic Research"},{"issue":"4","key":"10.1002\/14651858.CD005184.pub2-BIB0013|cit13","first-page":"321","article-title":"[The efficacy of creatine phosphate in the treatment of patients with heart failure. Its echographic evaluation after acute and protracted treatment]","volume":"144","author":"Cafiero","year":"1994 Apr","journal-title":"Clin Ter"},{"issue":"1","key":"10.1002\/14651858.CD005184.pub2-BIB0014|cit14","first-page":"17","article-title":"Multicenter clinical study of phosphocreatinine effects and tolerability","volume":"106","author":"Chiandussi","year":"1991","journal-title":"Riforma medica"},{"issue":"10","key":"10.1002\/14651858.CD005184.pub2-BIB0015|cit15","first-page":"671","article-title":"[Evaluation of the effects on the peripheral blood circulation of i.v. administration of high doses of phosphocreatinine in patients with arterial diseases]","volume":"34","author":"de","year":"1986","journal-title":"Minerva cardioangiologica 0026-4725"},{"issue":"7","key":"10.1002\/14651858.CD005184.pub2-BIB0016|cit16","first-page":"15","article-title":"[Neoton in the treatment of myocardial infarct and unstable stenocardia]","volume":"33","author":"Golikov","year":"1993","journal-title":"Kardiologiia"},{"key":"10.1002\/14651858.CD005184.pub2-BIB0017|cit17","first-page":"39","article-title":"Treatment with creatine phosphate in patients with heart failure: a multicenter study.","volume":"10","author":"Grazioli","year":"1989","journal-title":"Giornale Italiano Di Ricerche Cliniche E Terapeutiche"},{"issue":"6","key":"10.1002\/14651858.CD005184.pub2-BIB0018|cit18","first-page":"285","article-title":"Cardiodynamic alterations induced by treatment with phosphocreatinine","volume":"140","author":"Montanari","year":"1981","journal-title":"Gazzetta medica italiana"},{"issue":"9","key":"10.1002\/14651858.CD005184.pub2-BIB0019|cit19","first-page":"45","article-title":"[Neoton (exogenic phosphocreatinine) in combined therapy of chronic cardiac failure]","volume":"74","author":"Nedoshivin","year":"1996","journal-title":"Klin Med"},{"issue":"1","key":"10.1002\/14651858.CD005184.pub2-BIB0020|cit20","first-page":"19","article-title":"[Exogenous phosphocreatine in the prevention and treatment of cardiac insufficiency in patients with myocardial infarction]","volume":"71","author":"Perepech","year":"1993","journal-title":"Klin Med"},{"issue":"10","key":"10.1002\/14651858.CD005184.pub2-BIB0021|cit21","first-page":"52","article-title":"Prophylactic use of Neoton in cardiac failure in patients with myocardial infarction]","volume":"75","author":"Perepech","year":"1997","journal-title":"Klin Med (Mosk)"},{"key":"10.1002\/14651858.CD005184.pub2-BIB0022|cit22","first-page":"50","article-title":"[Neoton and thrombolytic therapy of myocardial infarction]","volume":"73(9)","author":"Perepech","year":"2001","journal-title":"Ter Arkh"},{"issue":"4","key":"10.1002\/14651858.CD005184.pub2-BIB0023|cit23","first-page":"345","article-title":"Phosphocreatine in acute myocardial infarction: multicenter randomized study","volume":"11","author":"Reimers","year":"1994","journal-title":"Il Cuore"},{"issue":"2","key":"10.1002\/14651858.CD005184.pub2-BIB0024|cit24","first-page":"136","article-title":"[The effect of creatine phosphate (Neoton) in acute myocardial infarct (a prospective multicenter pilot study]","volume":"39","author":"Stejfa","year":"1993","journal-title":"Vnitr Lek"},{"key":"10.1002\/14651858.CD005184.pub2-BIB0025|cit25","first-page":"15","article-title":"Assessment of cardiac arrythmias in patients with newly diagnosed myocardial infarction treated with Neoton (phosphocreatine)","volume":"47","author":"Tomaszewski","year":"1994","journal-title":"Medical Journal"},{"issue":"2","key":"10.1002\/14651858.CD005184.pub2-BIB0026|cit26","first-page":"53","article-title":"Use of creatine phosphate in treatment of cardiocerebral syndrome associated with acute myocardial infarct in the aged","volume":"134","author":"Weber","year":"1995","journal-title":"Cas Lek Cesk"},{"key":"10.1002\/14651858.CD005184.pub2-BIB0027|cit27","first-page":"91","article-title":"Dynamics of some biochemical indices in myocardial infarction treated with thrombolysis and creatine phosphate.","volume":"140","author":"Weinbergov\u00e1","year":"1996","journal-title":"Acta Universitatis Palackianae Olomucensis Facultatis Medicae"},{"issue":"11","key":"10.1002\/14651858.CD005184.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1097\/00004872-200018110-00002","article-title":"Is greater tissue activity of creatine kinase the genetic factor increasing hypertension risk in black people of sub-Saharan African descent?","volume":"18","author":"Brewster","year":"2000 Nov","journal-title":"J Hypertens"},{"key":"10.1002\/14651858.CD005184.pub2-BIB0029|cit29","first-page":"2034","article-title":"Creatine kinase activity is associated with blood pressure","volume":"114(19)","author":"Brewster","journal-title":"Circulation"},{"issue":"1","key":"10.1002\/14651858.CD005184.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0008-6363(95)00225-1","article-title":"Creatine supplementation in congestive heart failure","volume":"31","author":"Field","year":"1996 Jan","journal-title":"Cardiovasc Res"},{"key":"10.1002\/14651858.CD005184.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1161\/01.RES.0000137170.41939.d9","article-title":"Is the failing heart energy starved? On using chemical energy to support cardiac function","volume":"95(2)","author":"Ingwall","year":"2004","journal-title":"Circ Res"},{"issue":"11","key":"10.1002\/14651858.CD005184.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1056\/NEJMra063052","article-title":"The failing heart--an engine out of fuel","volume":"356","author":"Neubauer","year":"2007","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1002\/14651858.CD005184.pub2-BIB0033|cit33","first-page":"533","article-title":"Is creatine supplementation helpful for patients with chronic heart failure?","volume":"19","author":"Schaufelberger","year":"1998 Apr","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1002\/14651858.CD005184.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1152\/physrev.2000.80.3.1107","article-title":"Creatine and creatinine metabolism","volume":"80","author":"Wyss","year":"2000","journal-title":"Physiol Rev"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD005184.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T14:46:45Z","timestamp":1762526805000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD005184.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Hypertension Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2011,11,9]]},"references-count":34,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2011,11]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd005184.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,9]]}}}